This is a preview of subscription content, log in via an institution to check access.
Reference
Harrison RF, et al. Patient cost-sharing during poly(ADP-ribose) polymerase inhibitor treatment in ovarian cancer. American Journal of Obstetrics and Gynecology : 4 Feb 2021. Available from: URL: http://doi.org/10.1016/j.ajog.2021.01.029
Rights and permissions
About this article
Cite this article
High levels of cost-sharing during PARP inhibitor treatment for ovarian cancer in the US. PharmacoEcon Outcomes News 872, 16 (2021). https://doi.org/10.1007/s40274-021-7489-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-021-7489-2